Barriers to Referring Adolescent Women for Etonogestrel Implant.

Nemours Children's Health

Status: Withdrawn

Conditions: Contraceptive Usage

Treatments: Behavioral: Education plus Coaching

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT04882137

1692814

Details and patient eligibility

About

This study seeks to understand how much pediatric providers in Central Florida know about the etonogestrel contraceptive implant. The investigators also seek to understand the barriers that may prevent them from referring adolescent women for this highly effective and recommended method of contraception. Finally the study will consider if an expanded education and coaching improves their ability to referring patients for this method of birth control.

Full description

This study is comprised of two phases. During the first phase 500 medical providers who provide care to adolescents will be recruited to complete a 30 question anonymous survey that evaluates their attitudes towards recommending and referring for adolescent women for the etonogestrel contraceptive device. This survey will also test participant's knowledge of indications, side effects and side effect management related to this contraceptive device as well.

During phase 2, 100 pediatric providers will be randomized to two groups. One group will receive standard continuing medical education on the use of the etonogestrel device in adolescents focusing on themes that emerged as knowledge deficits in phase 1. The other group will receive standard continuing medical education plus continued coaching on management of medication side effects. The referring patterns of physicians in each group will be studied.

Sex: All

Ages: 22+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• A primary care provider that cares for children under the age of 18. This includes physician's assistants, advanced nurse practitioners, residents or fellows, and physicians in pediatrics, internal medicine, and family medicine.
• Must currently be practicing in Central Florida.
• Be able to speak and write in English
• For phase two of the study an additional requirement is that you must have a medical license to practice independently in the state of Florida.

Exclusion criteria

• Not a primary care provider who cares for children.
• A pediatric provider who only provides specialty care
• Not able to speak or write in English
• For phase two of study does not have a medical license to practice independenly in the State of Florida.

Trial design

Primary purpose: Health Services Research

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

0 participants in 2 patient groups

Standard Education

No Intervention group

Description:

Pediatric Providers in this arm will receive a continuing medical education on etonogestrel contractive implant but will not receive specialist coaching on how to manage side effects.

Standard Education plus Coaching

Experimental group

Description:

Pediatric Providers in this arm will receive a continuing medical education program on etonogestrel contraceptive implant. Providers in this arm will also receive a tip-sheet on how to manage side effects as well as a number to directly access a specialist who places them if needed.

Treatment:

Behavioral: Education plus Coaching